Skip to main content
. 2019 Nov 21;19(1):762–770. doi: 10.3892/etm.2019.8225

Table I.

Sequences of primers used in the study.

Gene Sequence reverse (5′-3′) Forward
CYR61 ATCGAGATCTGGAGAAGGCGGAG GGCGCGG ATCGAGATCTAATGGAGCCAGGGGAGGCG
VEGFR1 AAGAGAGCTTCCGTAAGGCG GCATCCTCTTCAGTTACGTCC
VEGFR2 GGAAGCTCCTGAAGATCTGT GAGGATATTTCGTGCCGCGC
VEGFR3 AGTCACACGTCATCGACACC ATTGGGACAGCTTGGATCAC
FGFR1 CACATCGAGGTGAACGGGAGTAAG CGCATCCTCAAAGGAGACATTCC
FGFR2 GGAAAGTGTGGTCCCATCTGA TCCAGGTGGTACGTGTGATTG
FGFR3 CATTGGAGGCATAAGCTG AGCACGGTAACGTAGGGTGT
FGFR4 GCAACTCCATCGGCCTTTCCTACCAG AGAACCAGTGAGCCTGATACATACAG
Vimentin E-cadherin TGGAGGAATTCTTGCTTTGC CGTACATGTCAGCCAGCTTC
Slug TATTTGGTTGGTCAGCACAGG GACGCAATCAATGTTTACTCG
MMP-1 TTCCACAGGTCCCACAAC GCATTCCTCACAGCCAAC
MMP-9 TGGGCTACGTGACCTATGACAT GTATGGTCGTGGCTCTAAGC
CPI GGGATTCCCTGGACCTAAAG GGAACACCTCGCTCTCCA
Fibronectin CCAGGCAGTACAATGTGGGT TGGAATAGAGCTCCCAGGCT
Cytochalasin-D GGTATTCAGCCAAACGACCA CCTCTCACTCGGTTCTCGAT
G-actin CCAGGGCTTTTCAAAAATGA CCGATCCAATCTGTTCTGGT
β-actin CGGAGTCAACGGATTTGGTC AGCCTTCTCCATGGTCGTGA

MMP, matrix metalloproteinase; CPI, collagen type I; FGFR, fibroblast growth factor receptor; VEGFR, vascular endothelial growth factor receptor; CYR61, cysteine-rich angiogenic inducer 61.